A Functional Amino Acid Substitution in the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Gene Is Associated With Lower Bone Mineral Density and Increased Fracture Risk
Open Access
- 1 April 2014
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 99 (4) , E729-E733
Abstract
Context: Food ingestion decreases bone resorption, and glucose-dependent insulinotropic polypeptide (GIP) may mediate this effect. Mice overexpressing GIP have increased osteoblast activity and are rescued from age-related bone loss, whereas GIPR knockout mice have decreased cortical bone mass and compromised bone quality. Carriers of the functional variant GIPR Glu354Gln (rs1800437) have higher plasma glucose 2 hours after glucose ingestion, suggesting that the variant encoding GIPR 354Gln decreases the effect of GIP. Objective: The objective of the study was to investigate the effect of GIPR Glu354Gln on bone mineral density (BMD) and fracture risk. Design: This was a prospective, comprehensive, cohort study (number NCT00252408). Participants: A total of 1686 perimenopausal women were included. Main Outcome Measures: Dual-energy X-ray absorptiometry was performed at baseline and after 10 years. Incident fractures were recorded during the follow-up and were obtained from the Danish National Patient Registry, giving a total follow-up time of a minimum 16 years. Results: After 10 years, women with the minor frequency C allele of rs1800437 (354Gln) had significantly lower BMD at the femoral neck compared with carriers of the major G-allele (CC: 0.755 ± 0.015 g/cm2 vs CG: 747 ± 0.005 g/cm2; GG: 0.766 ± 0.004 g/cm2, P < .001). Correspondingly, total hip BMD was significantly lower among C allele carriers (CC: 0.881 ± 0.016 g/cm2; CG: 0.884 ± 0.005 g/cm2; and GG: 0.906 ± 0.004 g/cm2, P < .001). Finally, women homozygous for the variant C allele had an increased risk (hazard ratio 1.6, confidence interval 1.0–2.6, P < .05) of nonvertebral fractures. Conclusion: This study demonstrates an association between a functional GIPR polymorphism Glu354Gln (rs1800437) and BMD and fracture risk. These findings further establish GIP to be involved in the regulation of bone density.Keywords
This publication has 17 references indexed in Scilit:
- Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in miceBone, 2013
- Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fractureNature Genetics, 2012
- Pharmacological Characterization of Human Incretin Receptor Missense VariantsThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Impact of Glucose-Dependent Insulinotropic Peptide on Age-Induced Bone LossJournal of Bone and Mineral Research, 2008
- Effects of glucose-dependent insulinotropic peptide on osteoclast functionAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Pharmacogenomic and Structural Analysis of Constitutive G Protein–Coupled Receptor ActivityAnnual Review of Pharmacology and Toxicology, 2007
- Gastric Inhibitory Polypeptide as an Endogenous Factor Promoting New Bone Formation after Food IngestionMolecular Endocrinology, 2006
- Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effectsMolecular and Cellular Endocrinology, 2001
- The Danish osteoporosis prevention study (DOPS): project design and inclusion of 2000 normal perimenopausal womenMaturitas, 1999
- Cross calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurementsBone, 1995